Welcome to our dedicated page for REGENCY CENTERS SEC filings (Ticker: REGCP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on REGENCY CENTERS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into REGENCY CENTERS's regulatory disclosures and financial reporting.
LINNEMAN PETER reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director Peter Linneman received an award of 318 shares of Common Stock on August 7, 2026, representing director's fees paid in stock under the company's Omnibus Incentive Plan. After this stock-settled fee, he directly owns 56,061 shares of Regency Centers.
Klein Karin reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director Karin Klein received a grant of 382 shares of common stock on August 7, 2026, as director’s fees paid in stock under Regency’s Omnibus Incentive Plan. Following this stock-based fee payment, Klein directly holds 25,790 shares of Regency Centers common stock.
Parrell Mark J. reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director Mark J. Parrell received a 334-share grant of common stock on August 7, 2026 as director's fees paid in stock under Regency's Omnibus Incentive Plan. Following this equity award, he directly holds 686 shares of Regency Centers common stock.
BLANKENSHIP C RONALD reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp director C. Ronald Blankenship received a grant of 167 shares of Common Stock on August 7, 2026, as director's fees paid in stock under Regency's Omnibus Incentive Plan. After this stock-based fee award, he directly holds 114,923 shares of Regency Centers common stock.
Regency Centers Corp is reported to have 7,731,712 shares of its common stock, or 4.2% of the class, beneficially owned by Principal Global Investors LLC and Principal Real Estate Investors LLC as of June 30, 2026. The filing states this represents ownership of 5 percent or less of the class.
Principal Global Investors LLC has shared voting and dispositive power over 1,204,484 shares, while Principal Real Estate Investors LLC has shared voting and dispositive power over 6,527,228 shares. Neither entity reports sole voting or sole dispositive power over any shares. The two Delaware-organized entities file jointly under a Joint Filing Agreement signed by their Chief Compliance Officer for North America.
REGENCY CENTERS CORP Principal Accounting Officer Terah L. Devereaux reported two common stock transactions. On June 12, 2026, Devereaux made an open-market sale of 1,240 shares of common stock at $80.135 per share and also disposed of 620 shares as a bona fide gift for no consideration.
Regency Centers Corp: Institutional investors Principal Global Investors and Principal Real Estate Investors LLC reported combined beneficial ownership of 9,730,877 shares, representing 5.3% of common stock as of 03/31/2026. The filing shows shared voting and dispositive power split: 1,400,150 shares (Principal Global Investors) and 8,330,727 shares (Principal Real Estate Investors LLC).
Regency Centers Corp director Bryce Blair reported stock-based compensation activity involving the vesting of previously granted awards. On May 11, 2026, restricted stock units and related dividend equivalent rights vested under Regency’s Omnibus Incentive Plan and were settled in shares of common stock.
The filing shows 1,736 shares of restricted stock converting into common stock, along with 71 dividend equivalent rights that also converted into common shares on a one-for-one basis. These are non-cash, compensation-related exercises rather than open-market purchases or sales, and reflect routine equity award vesting for a board member.
REGENCY CENTERS CORP director Peter Linneman increased his holdings through equity compensation. On May 11, 2026, he acquired a total of 1,807 shares of common stock via the vesting of restricted stock and settlement of related dividend equivalent rights under Regency's Omnibus Incentive Plan.
These transactions were recorded as exercises or conversions of derivative securities rather than open-market purchases or sales. Following the transactions, Linneman directly holds 55,743 shares of Regency common stock.
Regency Centers director C. Ronald Blankenship reported routine equity compensation vesting. On May 11, 2026, he acquired 1,952 shares of Regency Centers common stock through the vesting and settlement of restricted stock and related dividend equivalent rights under the company’s Omnibus Incentive Plan. These transactions reflect compensation-related exercises, not open‑market purchases or sales, and left him holding 114,679 common shares directly.